Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Vijay Kunadian Added: 1 year ago
This video series includes a symposium first presented at ESC 2024 held in London, where Prof Roxana Mehran, Prof Vijay Kunadian, Dr Didier Tchetche, Dr Julia Grapsa and Dr Joanna J Wykrzykowska discuss transforming TAVI practice. The discussion covers topics such as the SMART trial, a comparison of the most commonly used TAVI valves and strategies to address disparities in diagnosing aortic… View more
Author(s): Nadira Hamid , Rahul P Sharma Added: 1 week ago
TCT 2025 — Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr Rahul P Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease.The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricuspid disease, 7-year PARTNER 3 durability outcomes in TAVR, national prevalence insights from the PREVUE-VALVE study, and… View more
Advancing AVR

Video Series

Author(s): Christopher M Cook , Pilar Jimenez-Quevedo , Clare Appleby , et al Added: 2 weeks ago
Aortic valve replacement (AVR) continues to evolve, with new evidence, technologies and guidelines shaping best practice for lifetime management. This recording of the live webinar brings together leading experts to review the valvular heart disease 2025 ESC/EACTS guidelines, explore the latest data – including on asymptomatic severe AS –and highlight the role of RESILIA tissue technology and the… View more
Author(s): Flavio Ribichini , Philipp E Bartko , Stephen Dorman , et al Added: 11 months ago
Moderator Prof Flavio Ribichini (University of Verona, IT) is joined by Dr Hendrik Ruge (German Heart Center Munich, DE), Dr Philipp Bartko (Vienna General Hospital, AT), Dr Stephen Dorman (Bristol Heart Institute, UK) and Dr Nihal Wilde (Bundeswehr Central Hospital, DE), they focus on contemporary lifetime management in transcatheter aortic valve implantation (TAVI).Faculty explore the evolving… View more
Added: 1 week ago Source:  Radcliffe Cardiology
Long-term data from the PARTNER 3 trial show no significant differences in key clinical outcomes at 7 years between transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement (SAVR) for low-risk patients with severe, symptomatic aortic stenosis.¹ This extended follow-up provides crucial insights into the durability and long-term safety of both procedures in this patient… View more
Author(s): Julia Grapsa , Vijay Kunadian , Stephan Windecker , et al Added: 2 months ago
The ESC Congress 2025 symposium, “Transforming the Care of Female and Low-Risk Younger Patients With Aortic Stenosis Through Guidelines” is now available on demand.Chaired by Prof Stephan Windecker (Bern University Hospital, Bern, Switzerland) and Prof Vijay Kunadian (Newcastle University, Newcastle-upon-Tyne, UK), this session explores evolving strategies to optimise care for women and younger… View more
Author(s): Sahil Parikh Added: 1 week ago
TCT 2025 - Three-year findings from LIFE-BTK show the Esprit™ BTK scaffold is a durable and effective treatment option for patients with CLTI.Dr Sahil Parikh (Columbia University Vagelos College of Physicians & Surgeons, New York, US) joins us to share the three-year findings from LIFE-BTK (NCT04227899). The randomized controlled trial aimed to evaluate the safety and efficacy of the Esprit™ BTK… View more
Author(s): Flavio Ribichini , Philipp E Bartko , Stephen Dorman , et al Start date: Dec 05, 2024
Moderator Prof Flavio Ribichini (University of Verona, IT) is joined by Dr Hendrik Ruge (German Heart Center Munich, DE), Dr Philipp Bartko (Vienna General Hospital, AT), Dr Stephen Dorman (Bristol Heart Institute, UK) and Dr Nihal Wilde (Bundeswehr Central Hospital, DE) in this one hour webinar focusing on contemporary lifetime management in transcatheter aortic valve implantation (TAVI).Faculty… View more
Author(s): Mohamed Marwan Added: 2 months ago
Explore the evolving paradigm of lifetime management in TAVI with Dr Mohamed MarwanThis presentation addresses the critical shift from single-procedure focus to comprehensive lifetime planning in TAVI management. As guidelines expand to include patients as young as 65 years old, Dr Marwan examines the unique considerations that arise when treating more active individuals who may require future… View more